Seeking Alpha

Shares of Vitamin Shoppe (VSI +9.1%) soar after the company beats on both lines of its Q1...

Shares of Vitamin Shoppe (VSI +9.1%) soar after the company beats on both lines of its Q1 report. CEO Tony Truesdale says on a CC (webcast) that the recent FDA warning on DMAA won't have a material impact on earnings, as the company plans to keep products with the supplements on its shelves until the FDA acts.
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|